Sunil Healthcare (NSE:SUNLOC) Cyclically Adjusted PS Ratio: (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNLOC Sunil Healthcare Ltd NSE:SUNLOC
48 GF Score
Price ₹68.00
GF Value ₹66.99
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sunil Healthcare  (NSE:SUNLOC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sunil Healthcare Cyclically Adjusted PS Ratio Related Terms


Sunil Healthcare Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Sunil Healthcare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunil Healthcare Cyclically Adjusted PS Ratio Chart

Sunil Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.54 0.56 0.59 0.55

Sunil Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.76 0.70 0.64 0.55

NSE:SUNLOC vs : Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sunil Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunil Healthcare Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunil Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sunil Healthcare's Cyclically Adjusted PS Ratio falls into.


NSE:SUNLOC
48GF Score
Sunil Healthcare Ltd NSE:SUNLOC
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sunil Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Sunil Healthcare's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.253/330.2130*330.2130
=19.253

Current CPI (Mar. 2026) = 330.2130.

Sunil Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201509 16.551 237.945 22.969
201512 24.276 236.525 33.892
201603 22.153 238.132 30.719
201606 20.424 241.018 27.982
201609 23.614 241.428 32.298
201612 27.220 241.432 37.230
201703 27.098 243.801 36.703
201803 0.000 249.554 0.000
201806 19.061 251.989 24.978
201809 21.097 252.439 27.597
201812 20.541 251.233 26.998
201903 17.974 254.202 23.349
201906 17.743 256.143 22.874
201909 16.254 256.759 20.904
201912 17.694 256.974 22.737
202003 15.159 258.115 19.393
202006 20.582 257.797 26.364
202009 22.850 260.280 28.989
202012 23.206 260.474 29.419
202103 21.617 264.877 26.949
202106 25.488 271.696 30.978
202109 29.407 274.310 35.400
202112 30.722 278.802 36.387
202203 31.197 287.504 35.831
202206 32.569 296.311 36.295
202209 29.826 296.808 33.183
202212 25.374 296.797 28.231
202303 20.670 301.836 22.613
202306 22.098 305.109 23.916
202309 23.078 307.789 24.759
202312 22.668 306.746 24.402
202403 20.829 312.332 22.021
202406 20.833 314.175 21.896
202409 19.582 315.301 20.508
202412 20.067 315.605 20.996
202503 20.416 319.799 21.081
202506 22.198 322.561 22.725
202509 22.884 324.800 23.265
202512 21.269 324.054 21.673
202603 19.253 330.213 19.253

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Sunil Healthcare (NSE:SUNLOC) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be overvalued. The current stock price of ₹68.00 is trading 1.5% above its estimated GF Value™ of ₹66.99. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for NSE:SUNLOC:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹66.99 vs. price of ₹68.00 (1.5% above fair value)
  • GF Score™: 48/100 with 7 warning signs

No single metric tells the full story. See the NSE:SUNLOC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunil Healthcare Business Description

Comparable Companies
Other Exchanges 537253:India
Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
48GF Score

Get the complete analysis for NSE:SUNLOC

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.00
Price
₹66.99
GF Value